Clinical Trial Update: A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how a new long-acting insulin, Insulin Icodec, behaves in people with liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Icodec (insulin icodec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED